Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Tettamanti, Sarah
[Clear All Filters]
2023
Biondi M
,
Tettamanti S
,
Galimberti S
,
Cerina B
,
Tomasoni C
,
Piazza R
,
Donsante S
,
Bido S
,
Perriello VMaria
,
Broccoli V
, et al.
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden.
Blood. 2023.
PubMed
Google Scholar
2022
Perriello VMaria
,
Rotiroti MCaterina
,
Pisani I
,
Galimberti S
,
Alberti G
,
Pianigiani G
,
Ciaurro V
,
Marra A
,
Sabino M
,
Tini V
, et al.
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML.
Blood Adv. 2022.
PubMed
Google Scholar
2020
Magnani CF
,
Gaipa G
,
Lussana F
,
Belotti D
,
Gritti G
,
Napolitano S
,
Matera G
,
Cabiati B
,
Buracchi C
,
Borleri G
, et al.
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities.
J Clin Invest. 2020.
PubMed
Google Scholar
2014
Tettamanti S
,
Biondi A
,
Biagi E
,
Bonnet D
.
CD123 AML targeting by chimeric antigen receptors: A novel magic bullet for AML therapeutics?
. Oncoimmunology. 2014;3:e28835.
PubMed
Google Scholar
2013
Magnani CF
,
Tettamanti S
,
Maltese F
,
Turazzi N
,
Biondi A
,
Biagi E
.
Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives.
Front Oncol. 2013;3:106.
PubMed
Google Scholar